Clinical Trial Update: Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing the efficacy and safety of memantine combined with sodium oligomannate in patients with moderate to severe Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)
• Sodium oligomannate (sodium oligomannate)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Treatment, Efficacy | Phase 4 | Status: UNKNOWN